Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.
Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T. Toi M, et al. Among authors: chow lw. Breast Cancer Res Treat. 2012 Dec;136(3):919-26. doi: 10.1007/s10549-012-2333-9. Epub 2012 Nov 11. Breast Cancer Res Treat. 2012. PMID: 23143284
Personalization of loco-regional care for primary breast cancer patients (part 1).
Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference. Toi M, et al. Among authors: chow lw. Future Oncol. 2015;11(9):1297-300. doi: 10.2217/fon.15.65. Future Oncol. 2015. PMID: 25952777 Free article.
Personalization of loco-regional care for primary breast cancer patients (part 2).
Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference. Toi M, et al. Among authors: chow lw. Future Oncol. 2015;11(9):1301-5. doi: 10.2217/fon.15.66. Future Oncol. 2015. PMID: 25952778 Free article.
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique.
Takada M, Sugimoto M, Ohno S, Kuroi K, Sato N, Bando H, Masuda N, Iwata H, Kondo M, Sasano H, Chow LW, Inamoto T, Naito Y, Tomita M, Toi M. Takada M, et al. Among authors: chow lw. Breast Cancer Res Treat. 2012 Jul;134(2):661-70. doi: 10.1007/s10549-012-2109-2. Epub 2012 Jun 12. Breast Cancer Res Treat. 2012. PMID: 22689089
Translational research in breast cancer.
Toi M, Takebayashi Y, Chow LW. Toi M, et al. Among authors: chow lw. Breast Cancer. 2005;12(2):86-90. doi: 10.2325/jbcs.12.86. Breast Cancer. 2005. PMID: 15858437 Free article. Review.
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy.
Ohno S, Chow LW, Sato N, Masuda N, Sasano H, Takahashi F, Bando H, Iwata H, Morimoto T, Kamigaki S, Nakayama T, Nakamura S, Kuroi K, Aogi K, Kashiwaba M, Yamashita H, Hisamatsu K, Ito Y, Yamamoto Y, Ueno T, Fakhrejahani E, Yoshida N, Toi M. Ohno S, et al. Among authors: chow lw. Breast Cancer Res Treat. 2013 Nov;142(1):69-80. doi: 10.1007/s10549-013-2691-y. Breast Cancer Res Treat. 2013. PMID: 24122389 Free PMC article. Clinical Trial.
210 results